Methods and compositions for treating solid tumors

Details Methods and compositions for treating solid tumors Methods and compositions for treating solid tumors

2006-09-05

2006-09-05

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S501000, C424S502000, C514S772300

Reexamination Certificate

active

07101568

ABSTRACT:
A biodegradable polymer composition comprising:(a) a poly(phosphoester) biodegradable polymer and(b) at least one antineoplastic agent in an amount effective to inhibit the growth of a solid tumor, whichis suitable for intratumoral administration to treat a mammal having a solid tumor.

REFERENCES:
patent: 3271329 (1966-09-01), Coover et al.
patent: 3442982 (1969-05-01), Friedman
patent: 3927231 (1975-12-01), Desitter et al.
patent: 3932566 (1976-01-01), Reader
patent: 4100354 (1978-07-01), Owen
patent: 4259222 (1981-03-01), Login et al.
patent: 4328174 (1982-05-01), Schmidt et al.
patent: 4474937 (1984-10-01), Bales
patent: 4481353 (1984-11-01), Nyilas et al.
patent: 4757128 (1988-07-01), Domb et al.
patent: 4789724 (1988-12-01), Domb et al.
patent: 4978332 (1990-12-01), Luck et al.
patent: 5162115 (1992-11-01), Pietnegro
patent: 5194581 (1993-03-01), Leong
patent: 5213804 (1993-05-01), Martin et al.
patent: 5256765 (1993-10-01), Leong
patent: 5304377 (1994-04-01), Yamada
patent: 5429634 (1995-07-01), Narciso et al.
patent: 5530093 (1996-06-01), Engelhardt et al.
patent: 5626862 (1997-05-01), Brem et al.
patent: 5637085 (1997-06-01), Cardinale
patent: 5651986 (1997-07-01), Brem et al.
patent: 5846565 (1998-12-01), Brem et al.
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5912225 (1999-06-01), Mao et al.
patent: 5952451 (1999-09-01), Zhao
patent: 5993856 (1999-11-01), Ragavan et al.
patent: 6008318 (1999-12-01), Zhao et al.
patent: 6028163 (2000-02-01), Zhao
patent: 6153212 (2000-11-01), Mao et al.
patent: 6166173 (2000-12-01), Mao et al.
patent: 6322797 (2001-11-01), Mao et al.
patent: 6350464 (2002-02-01), Dang
patent: 6376644 (2002-04-01), Mao et al.
patent: 6403675 (2002-06-01), Dang et al.
patent: 6419709 (2002-07-01), Mao et al.
patent: 6479067 (2002-11-01), Dang
patent: 6485737 (2002-11-01), Mao et al.
patent: 6600010 (2003-07-01), Mao et al.
patent: 6641833 (2003-11-01), Dang
patent: 2002/0045668 (2002-04-01), Dang et al.
patent: 2002/0137814 (2002-09-01), Dang et al.
patent: 2002/0198135 (2002-12-01), Dang et al.
patent: 2003/0133903 (2003-07-01), Dang et al.
patent: 2003/0134892 (2003-07-01), Dang et al.
patent: 2004/0071774 (2004-04-01), Dang
patent: 0 057 116 (1982-08-01), None
patent: 0 193 019 (1986-09-01), None
patent: 0 386 757 (1990-09-01), None
patent: P0001256 (1998-10-01), None
patent: P0202670 (2002-02-01), None
patent: WO 94/23699 (1994-10-01), None
patent: WO 95/17901 (1995-06-01), None
patent: WO 96/03984 (1996-02-01), None
patent: WO 97/40085 (1997-10-01), None
patent: WO 98/42330 (1998-10-01), None
patent: WO 98/44020 (1998-10-01), None
patent: WO 98/44021 (1998-10-01), None
patent: WO 98/48859 (1998-11-01), None
patent: WO 98/58012 (1998-12-01), None
patent: WO 00/64437 (1999-04-01), None
patent: WO 00/19976 (2000-04-01), None
patent: WO 00/57852 (2000-05-01), None
patent: WO 00/416783 (2000-07-01), None
patent: WO 02/03957 (2002-01-01), None
Alkan-Onyuksel et al., “A Mixed Micellar Formulation Suitable for the Parenteral Administration of Taxol,” Pharmaceutical Research, 11(2):206-211 (1994).
Auerbach et al., “Site-Specific Drug Delivery to the Lung,” Polymers for Advanced Technologies, vol. 3:323-329.
Bao et al., “A Controlled Release Paclitaxel Formulation (PACLIMER™ delivery system) has Superior Efficacy to Paclitaxel in an Ovarian Cancer Survival Model,” Proceeding of the American Association for Cancer Research (90thAnnual Meeting, Apr. 10-14, 1999) vol. 40, Abstract No. 3850 (Mar. 15, 1999).
Bruin et al., “Biodegradable Lysine Diisocyanate-based Poly(glycolide-co-ε-caprolactone)-urethane Network in Artificial Skin,” Biomaterials, 11(4):291-95 (1990).
Burt et al., “Controlled Delivery of Taxol from Microspheres Composes of a Blend of Ethylene-Vinyl Acetate Copolymer and Poly(d, l-lactic acid),” Cancer Letters, 88:73079 (1995).
Demetrick et al., “The Development of a Novel Intraperitoneal Tumor-Seeding Prophylactic,” The American Journal of Surgery®, vol. 173, May 1997.
Dordunoo et al., “Release of Taxol from Poly(ε-caprolactone) Pastes: Effect of Water-Soluble Additives,” Journal of Controlled Release, 44:87-94 (1997).
Fan, Chang-Lie et al., “Studies of the Drug Controlled-Release Materials of Polyphosphate Containing Tyrosine Ester,” Chemical Abstracts, 124(18): Abstract No. 24198 (Apr. 29, 1996).
Feng et al., “Nanospheres of Biodegradable Polymers: A System for Clincal Administration of an Anticancer Drug Paclitaxel (Taxol),” Ann Acad Singapore, 29:633-639 (2000).
Francis et al., “Phase I Feasibility and Pharmacologic Study of Weekly Intraperitoneal Paclitaxel: A Gynecologic Oncology Group Pilot Study,” Journal of Clincal Oncology, vol. 13, No. 12:2961-2967, Dec. (1995).
Fu et al., “Studies on the Melt Copolymerization of Phosphorous-Containing Diacid and BIS (p-Carboxyphenoxy) Propand for DDS,” J. Wuhan Univ. (Natural Science Edition), 43(4):467-470 (1997).
Fu et al., “Studies on the Syntheses and Drug Release Properties of Polyanhydrides Containing Phosphonoformic (or Acetic) Acid Ethyl Ester in the Main Chain,” Chemical Journal of Chinese Universities, 18(10)1706-1710 (1997).
Fu et al., “Studies on the Syntheses and Properties of Phosphorus-Containing Polyanhydrides for DDS,” Chemical Journal of Chinese Universities, 18(5)813-817 (1997).
Hagiwara et al., “Pharmacologic Effects of Cisplatin Microspheres on Peritoneal Carcinomatosis in Rodents,” Cancer, 71(3):844-850, Feb. (1993).
Harper et al., Enhanced Efficacy of Novel Controlled Release Paclitaxel Formulation (PACLIMER Delivery System) for Local-Regional Therapy of Lung Cancer Tumor Nodules in Mice, Clinical Cancer Research 5:4242-4248 (Dec. 1999).
Jameela et al., “Antitumour Activity of Mitoxantrone-loaded Chitosan Microspheres Against Ehrlich Ascites Carcinoma,” J. Pharm. Pharmacol., 48:685-688 (1996).
Kadiyala et al., “Poly(phosphoesters): Synthesis, Physicochemical Characterization and Biological Repsonse,” Biomedical Applications of Synthetic Biodegradable Polymers, Chapter 3: 33-57, (Jeffrey O. Hollinger ed., 1995).
Kaetsu et al., “Biodegradable Implant Composites for Local Therapy,” Journal of Controlled Release, 6:249-263 (1987).
Kumagai et al., “Improvement of Intraperitoneal Chemotherapy for Rat Ovarian Cancer Using Cisplatin-Containing Microspheres,” Jpn. J. Cancer Res., 87:412-417, Apr., (1996).
Langer et al., “New Methods of Drug Delivery,” Science, 249(4976):1527-33 (1990).
Leong et al., “Polymeric Controlled Drug Delivery,” Advanced Drug Delivery REviews, 1:199-233 (1987).
Liu et al. “Synthesis of Phosphatidyl Ethanolamine Polyphosphate Liposomal Materials,” Chemical Journal of Chinese Universities 18 (9):1556-1559 (1997).
Lo, Hungnan, “Synthesis of Biodegradable Polymers and Porous Grafts for Orthopedic Applications,” Thesis, Johns Hopkins University, Jan. 27, 1995.
Mao et al., Biodegradable Polymers: Poly(Phosphoesters, Encyclopedia of Controlled Drug Delviery, Wiley and Sons, pp. 45-60 (1999).
Mao et al., “Deisgn of New Biodegradable Polymers Based on Chain-Extension of Oligomeric Lactides by Phosphates,” Proceedings of the Topical Conference on Biomaterials Carriers for Drug Delivery and Scaffold for Tissue Engineering, Peppas, N.A. et al., eds. Los Angeles, CA, pp. 193-195 (1997).
Mao et al., “Synthesis and Biological Properties of Polymer Immunoadjuvants,” Polymer Journal, 25(5):499-505 (1993).
Owusu-Ababio et al., “Efficacy of Sustained Release Ciprofloxacin Microspheres Against Device-Associated Pseudomonas Aeruginosa Biofilm Infection in a Rabbit Peritoneal Model,” J. Med. Microbiol. Vo., 43:368-376 (1995).
Peo et al., “Biological Activity of Urease Formulated in Poloxamer 407 After Intraperitoneal Injection in the Rat,” Journal of Pharmaceutical Sciences, vol. 81:7, Jul. (1992

Affiliated with

Also associated with

Rating

Methods and compositions for treating solid tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating solid tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating solid tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3570297